Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
Stocks in this Quantisnow insightHealth Care
Historical context for XAIR
Across the 11 sessions after earlier XAIR headlines, the stock closed higher 6 times and lower 5 times, with a median move of 4.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | XAIR | SPY |
|---|---|---|---|
| Aug 13, 2026 | Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update | +14.4% | +0.7% |
| Aug 4, 2026 | Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026 | -2.4% | +1.8% |
| Jul 30, 2026 | Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules | -1.6% | +1.7% |
| Jun 26, 2026 | Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update | +3.7% | -0.7% |
| Jun 23, 2026 | Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast | +14.4% | -1.5% |
| Jun 10, 2026 | Beyond Air, Inc. Urges Stockholders to Vote "FOR" All Proposals Ahead of the Upcoming Special Meeting | -1.6% | -1.6% |
Quantisnow market dataNASDAQ
XAIR
Beyond Air Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for XAIR
Full XAIR profile on Quantisnow Follow XAIR and get a push notification the moment its next story breaks.